HUN vs PATH · rev $6.04B vs P/E 19, rev $1.61B
Huntsman Corporation (HUN) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Huntsman Corporation (HUN) is a chemicals company listed on NYSE.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported HUN revenue for 2024-12-31 was $6.04B. Net income was -$127.0M. Revenue was down 1.2% from 2023-12-31 to 2024-12-31. HUN currently screens at market cap $2.23B.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
HUN currently screens at market cap $2.23B. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the HUN and PATH stock pages for the full models.
Not investment advice.